Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

Financial writer analyzes 3M's Q3'24 results, highlighting margin expansion and earnings growth, but expresses caution due to ...

Evolv Technology Holdings, a leader in AI-based weapons detection, faces ongoing regulatory hurdles, making its current stock ...

Read here for an analysis of the top Berkshire Hathaway stocks for 2025 with high dividend potential and projected net gains, ...

BHP's low share price presents a great opportunity for long-term investors with strong financials and growth prospects in ...

Learn about the 4-factor dividend growth portfolio, its performance compared to the S&P 500 and SCHD, and its impressive CAGR ...

In particular, I highlighted Intapp’s strong top-line growth, top-tier retention, and modest valuation as the primary drivers ...

JMOM is rated as a hold due to mixed factors, including strong past performance but high valuations and risks for top ...

Financial writer warns of risks with iShares National Muni Bond ETF (MUB) due to anticipated inflation and Trump ...

Wave's (QBTS) financial performance, high valuations, and technical trends, cautioning against bullish sentiment.

Happy New Year! Kicking off 2025 with four companies offering inflation-beating dividend increases, averaging 10.8% with a ...

Invest in US regional banks with Direxion Daily Regional Banks Bull 3X Shares ETF for potential growth in 2025. Explore more ...